May 5, 20211 min

Biopharma Daily Stock Updates - 05/05/21

$XBI $128 -1%

Covid Updates

$MRNA -6% Initial data from ph 2 booster study in covid variants. source

$CYDY -5% Partner with ARO in Brazil for 2 Covid trials, critically-ill and severe patients. source

Pipeline Updates

$ZYNE +3% Received guidance from FDA for pivotal ph 3 trial of Zygel in Fragile X Syndrome, initiation planned for Q3 '21. source

$CBIO -2% Enrolled first patient in pivotal ph 3 trial (Crimson-01) of MarzAA for Hem A/B. source

$REPL +9% Update to ph 2 RP1 + Opdivo, CR as a PE, and target enrollment 180 patients. source

Financial Updates

$CRVS +6% Sold $10 shares through ATM program to EcoR1 Capital and CEO. source

$AMYT -7% to acquire $CHMA +44% source

$TLSA 0% Agreement with Takanawa to find partner in Japan and Asia for Milciclib for treatment in advanced hepatocellular carcinoma (HCC) patients. source

    0
    0